Neoadjuvant Treatment of Breast Cancer - Advances and Limitations (2016) Fasching P, Gaß P, Hein A Journal article The PI3K Pathway: Background and Treatment Approaches (2016) Lux MP, Fasching P, Schrauder MG, Hein A, Jud S, Rauh C, Beckmann M Journal article Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study (2016) Gaß P, Fasching P, Fehm T, De Waal J, Rezai M, Baier B, Baake G, et al. Journal article 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts (2015) Jackisch C, Harbeck N, Huober J, Von Minckwitz G, Gerber B, Kreipe HH, Liedtke C, et al. Journal article Romancing the Boost - the Higher, the Better? (2015) Sedlmayer F, Sautter-Bihl ML, Sauer R Journal article Is symptom-oriented follow-up still up to date? (2013) Mundhenke C, Moebus V Journal article, Review article Significance of tyrosine kinase inhibitors in the treatment of metastatic breast cancer (2009) Mundhenke C, Strauss A, Schem C Journal article, Review article